Summary
- Current Price
- As of today, IOVA price is $8.37, up +4.69% in the most recent trading session on
- Current Price All-Time High
- IOVA price is currently -94.93% below its historical high of $165.00 set on
- Market Cap
- IOVA current market cap is $4B, up +338.02% over the past 365 days
- Revenue
- IOVA current annual revenue is $263.50M, up +60.60% year-over-year
- Next Earnings
- The next earnings release for IOVA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Iovance Biotherapeutics, Inc. |
| Ticker | NASDAQ: IOVA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | iovance.com |
| Employees | 838 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $8.37 | |
| Price, 1D Change | +4.69% | |
| $4B | ||
| - | ||
| - | ||
| 1.37 | ||
| $263.50M | ||
| Revenue, 1Y Change | +60.60% | |
| -$1.09 | ||
| EPS, 1Y Change | +14.78% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:100 | |
| Next Split | N/A | N/A |
| Last Ticker Change | LBIO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.09 | ||
| EPS Estimate | -$0.48 | N/A |
| EPS Est. Change | +56.00% | N/A |
| $263.50M | ||
| Revenue Estimate | $399.75M | N/A |
| Revenue Est. Change | +51.71% | N/A |
| Current Price | $8.37 | |
| Price Target | $9.00 | - |
| Price Tgt. Change | +7.59% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.29 | -$1.28 | +0.47% | |
| -$1.08 | -$1.09 | -1.21% | |
| -$0.48 | N/A | +56.00% | |
| -$0.27 | N/A | +75.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $162.64M | $164.07M | +0.88% | |
| $258.36M | $263.50M | +1.99% | |
| $399.75M | N/A | +51.71% | |
| $541.97M | N/A | +105.68% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $8.37 | |
| $3.56 | ||
| $4.85 | ||
| $4.02 | ||
| $5.16 | ||
| $0.76 | ||
| 1.37 | ||
| $0.53 | ||
| 78.64 | ||
| 214.66% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $263.50M | ||
| -$1.09 | ||
| $54.38M | ||
| 20.64% | ||
| -$398.21M | ||
| -151.12% | ||
| -$390.98M | ||
| -148.38% | ||
| -$362.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 3.20 | ||
| 2.83 | ||
| - | ||
| 5 | ||
| 5.59 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 11.66 | ||
| 5.15 | ||
| -14.04 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $698.58M | ||
| $296.98M | ||
| $913.17M | ||
| $442.69M | ||
| $214.59M | ||
| $138.36M | ||
| $49.44M | ||
| $5.04M | ||
| $22.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $654.48M | ||
| $452.59M | ||
| $209.12M | ||
| $0.00 | ||
| $47.32M | ||
| $0.00 | ||
| -$2.07M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$302.41M | ||
| $47.50M | ||
| $300.77M | ||
| $33.84M | ||
| -$336.24M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Citizens | → | |
| Barclays | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| UBS | → | |
| Citizens | → | |
| Citizens | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with IOVA
FAQ
- What is the ticker symbol for Iovance Biotherapeutics, Inc.?
- The ticker symbol for Iovance Biotherapeutics, Inc. is NASDAQ:IOVA
- Does Iovance Biotherapeutics, Inc. pay dividends?
- No, Iovance Biotherapeutics, Inc. does not pay dividends
- What sector is Iovance Biotherapeutics, Inc. in?
- Iovance Biotherapeutics, Inc. is in the Healthcare sector
- What industry is Iovance Biotherapeutics, Inc. in?
- Iovance Biotherapeutics, Inc. is in the Biotechnology industry
- What country is Iovance Biotherapeutics, Inc. based in?
- Iovance Biotherapeutics, Inc. is headquartered in United States
- When did Iovance Biotherapeutics, Inc. go public?
- Iovance Biotherapeutics, Inc. initial public offering (IPO) was on October 15, 2010
- Is Iovance Biotherapeutics, Inc. in the S&P 500?
- No, Iovance Biotherapeutics, Inc. is not included in the S&P 500 index
- Is Iovance Biotherapeutics, Inc. in the NASDAQ 100?
- No, Iovance Biotherapeutics, Inc. is not included in the NASDAQ 100 index
- Is Iovance Biotherapeutics, Inc. in the Dow Jones?
- No, Iovance Biotherapeutics, Inc. is not included in the Dow Jones index
- When was Iovance Biotherapeutics, Inc. last earnings report?
- Iovance Biotherapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Iovance Biotherapeutics, Inc. report earnings?
- The next expected earnings date for Iovance Biotherapeutics, Inc. is November 5, 2026
Data Sources & References
- IOVA Official Website www.iovance.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1425205/000110465926018899/0001104659-26-018899-index.htm
- IOVA Profile on Yahoo Finance finance.yahoo.com/quote/IOVA
- IOVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iova